Search research articles
Contact Us
Filters
Showing results (91-100 of 491) with videos related to
Page
of 50
Sort By:
Journal of Health Economics and Outcomes Research
|
October 27, 2021
Erratum: Author Correction: Cost-effectiveness Analysis of Hypoallergenic Milk Formulas for the Management of Cow's Milk Protein Allergy in the United Kingdom
Rui Martins, Mark P Connolly, Eleanor Minshall
Provider (Washington, D.C.)
|
April 26, 2012
A look at MDS 3.0 psychosocial changes
Robert P Connolly, Deirdre Downes, Jake Reuter
Journal of Medical Economics
|
January 19, 2021
Estimating the public economic consequences of cardiovascular disease-attributable events and evolocumab treatment in Australia
Nikolaos Kotsopoulos, Mark P Connolly, Jinjing Li
Journal of Health Economics and Outcomes Research
|
August 25, 2021
Cost-effectiveness Analysis of Hypoallergenic Milk Formulas for the Management of Cow's Milk Protein Allergy in the United Kingdom
Rui Martins, Mark P Connolly, Eleanor Minshall
Current Opinion in Ophthalmology
|
January 25, 2002
Cataract surgery in patients with retinal disease
Matthew T S Tennant, Brian P Connolly
Postgraduate Medicine
|
February 9, 2018
Cutaneous irritancy of an ibuprofen medicated plaster in healthy volunteers
Manisha Maganji, Mark P Connolly, Aomesh Bhatt
The British Journal of General Practice : the Journal of the Royal College of General Practitioners
|
July 8, 2000
Repeat prescribing management
H McGavock, K Wilson-Davies, P Connolly
Archives of Oral Biology
|
January 1, 1982
The influence of the replacement of dietary sucrose by maltose on the formation and biochemistry of human dental plaque
A Skinner, P Connolly, M N Naylor
Health Economics Review
|
July 23, 2015
Quantifying the broader economic consequences of quadrivalent human papillomavirus (HPV) vaccination in Germany applying a government perspective framework
Nikolaos Kotsopoulos, Mark P Connolly, Vanessa Remy
The Netherlands Journal of Medicine
|
August 4, 2012
The economics of mesalazine in active ulcerative colitis and maintenance in the Netherlands
M P Connolly, C Boersma, B Oldenburg
Page
of 50
Search research articles
Search
Showing results (91-100 of 491) with videos related to
Sort By:
Page
of 50
Journal of Health Economics and Outcomes Research
|
October 27, 2021
Erratum: Author Correction: Cost-effectiveness Analysis of Hypoallergenic Milk Formulas for the Management of Cow's Milk Protein Allergy in the United Kingdom
Rui Martins, Mark P Connolly, Eleanor Minshall
Provider (Washington, D.C.)
|
April 26, 2012
A look at MDS 3.0 psychosocial changes
Robert P Connolly, Deirdre Downes, Jake Reuter
Journal of Medical Economics
|
January 19, 2021
Estimating the public economic consequences of cardiovascular disease-attributable events and evolocumab treatment in Australia
Nikolaos Kotsopoulos, Mark P Connolly, Jinjing Li
Journal of Health Economics and Outcomes Research
|
August 25, 2021
Cost-effectiveness Analysis of Hypoallergenic Milk Formulas for the Management of Cow's Milk Protein Allergy in the United Kingdom
Rui Martins, Mark P Connolly, Eleanor Minshall
Current Opinion in Ophthalmology
|
January 25, 2002
Cataract surgery in patients with retinal disease
Matthew T S Tennant, Brian P Connolly
Postgraduate Medicine
|
February 9, 2018
Cutaneous irritancy of an ibuprofen medicated plaster in healthy volunteers
Manisha Maganji, Mark P Connolly, Aomesh Bhatt
The British Journal of General Practice : the Journal of the Royal College of General Practitioners
|
July 8, 2000
Repeat prescribing management
H McGavock, K Wilson-Davies, P Connolly
Archives of Oral Biology
|
January 1, 1982
The influence of the replacement of dietary sucrose by maltose on the formation and biochemistry of human dental plaque
A Skinner, P Connolly, M N Naylor
Health Economics Review
|
July 23, 2015
Quantifying the broader economic consequences of quadrivalent human papillomavirus (HPV) vaccination in Germany applying a government perspective framework
Nikolaos Kotsopoulos, Mark P Connolly, Vanessa Remy
The Netherlands Journal of Medicine
|
August 4, 2012
The economics of mesalazine in active ulcerative colitis and maintenance in the Netherlands
M P Connolly, C Boersma, B Oldenburg
Page
of 50